Earnings Feed
Start Free
ANGIOTECH PHARMACEUTICALS INC·4/A

May 17, 6:11 PM ET

Diaz Victor Manuel 4/A

4/A · ANGIOTECH PHARMACEUTICALS INC · Filed May 17, 2011

Insider Transaction Report

Form 4/AAmended
Period: 2011-05-12
ANGIOTECH PHARMACEUTICALS INCANPI
Diaz Victor Manuel
Sr VP, Global Manufacturing
Transactions
  • Other

    Awards (Options w/Tandem SAR)

    2011-05-12−30,000→ 0 total
    Exercise: $5.69From: 2007-05-01Exp: 2012-04-26→ Common Stock (30,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−150,000→ 30,000 total
    Exercise: $0.16From: 2009-01-01Exp: 2013-12-07→ Common Stock (150,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−150,000→ 180,000 total
    Exercise: $0.27From: 2009-04-01Exp: 2014-03-09→ Common Stock (150,000 underlying)
  • Other

    Stock Option w/Tandem SAR

    2011-05-12−85,000→ 330,000 total
    Exercise: $1.05From: 2010-04-01Exp: 2015-03-07→ Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]Effective on May 12, 2011, all of the Company's existing common shares and options to acquire common shares were canceled without any payment or consideration therefor, in connection with the implementation of a plan of compromise or arrangement under the Companies' Creditors Arrangement Act (Canada).

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT